Adcock Ingram Holdings Limited (AIP) - Total Assets
Based on the latest financial reports, Adcock Ingram Holdings Limited (AIP) holds total assets worth ZAC8.74 Billion ZAC (≈ $4.64 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Adcock Ingram Holdings Limited's book value for net asset value and shareholders' equity analysis.
Adcock Ingram Holdings Limited - Total Assets Trend (2005–2025)
This chart illustrates how Adcock Ingram Holdings Limited's total assets have evolved over time, based on quarterly financial data.
Adcock Ingram Holdings Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
Adcock Ingram Holdings Limited's total assets of ZAC8.74 Billion consist of 60.0% current assets and 40.0% non-current assets.
| Asset Category | Amount (ZAC) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ZAC0.00 | 1.2% |
| Accounts Receivable | ZAC2.22 Billion | 25.4% |
| Inventory | ZAC2.81 Billion | 32.2% |
| Property, Plant & Equipment | ZAC0.00 | 0.0% |
| Intangible Assets | ZAC984.90 Million | 11.3% |
| Goodwill | ZAC176.34 Million | 2.0% |
Asset Composition Trend (2005–2025)
This chart illustrates how Adcock Ingram Holdings Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see AIP market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Adcock Ingram Holdings Limited's current assets represent 60.0% of total assets in 2025, a decrease from 63.8% in 2005.
- Cash Position: Cash and equivalents constituted 1.2% of total assets in 2025, down from 11.2% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, a decrease from 33.0% in 2005.
- Asset Diversification: The largest asset category is inventory at 32.2% of total assets.
Adcock Ingram Holdings Limited Competitors by Total Assets
Key competitors of Adcock Ingram Holdings Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
China | CN¥21.15 Billion |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE
|
India | Rs93.93 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
China | CN¥4.75 Billion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr67.43 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.02 Billion |
Adcock Ingram Holdings Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.06 | 1.93 | 1.76 |
| Quick Ratio | 0.95 | 0.93 | 0.89 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ZAC2.70 Billion | ZAC2.36 Billion | ZAC1.67 Billion |
Adcock Ingram Holdings Limited - Advanced Valuation Insights
This section examines the relationship between Adcock Ingram Holdings Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.82 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | 4.6% |
| Total Assets | ZAC8.74 Billion |
| Market Capitalization | $583.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values Adcock Ingram Holdings Limited's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Adcock Ingram Holdings Limited's assets grew by 4.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Adcock Ingram Holdings Limited (2005–2025)
The table below shows the annual total assets of Adcock Ingram Holdings Limited from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | ZAC8.74 Billion ≈ $4.64 Million |
+4.56% |
| 2024-06-30 | ZAC8.35 Billion ≈ $4.44 Million |
+1.12% |
| 2023-06-30 | ZAC8.26 Billion ≈ $4.39 Million |
+4.73% |
| 2022-06-30 | ZAC7.89 Billion ≈ $4.19 Million |
+12.06% |
| 2021-06-30 | ZAC7.04 Billion ≈ $3.74 Million |
-1.97% |
| 2020-06-30 | ZAC7.18 Billion ≈ $3.82 Million |
+14.89% |
| 2019-06-30 | ZAC6.25 Billion ≈ $3.32 Million |
-0.32% |
| 2018-06-30 | ZAC6.27 Billion ≈ $3.33 Million |
+12.72% |
| 2017-06-30 | ZAC5.56 Billion ≈ $2.96 Million |
-0.60% |
| 2016-06-30 | ZAC5.60 Billion ≈ $2.97 Million |
+2.54% |
| 2015-06-30 | ZAC5.46 Billion ≈ $2.90 Million |
+0.96% |
| 2014-06-30 | ZAC5.41 Billion ≈ $2.87 Million |
-20.72% |
| 2013-06-30 | ZAC6.82 Billion ≈ $3.62 Million |
+29.09% |
| 2012-06-30 | ZAC5.28 Billion ≈ $2.81 Million |
+0.89% |
| 2011-06-30 | ZAC5.24 Billion ≈ $2.78 Million |
+10.05% |
| 2010-06-30 | ZAC4.76 Billion ≈ $2.53 Million |
+40.44% |
| 2009-06-30 | ZAC3.39 Billion ≈ $1.80 Million |
+24.87% |
| 2008-06-30 | ZAC2.71 Billion ≈ $1.44 Million |
+16.51% |
| 2007-06-30 | ZAC2.33 Billion ≈ $1.24 Million |
-27.06% |
| 2006-06-30 | ZAC3.19 Billion ≈ $1.70 Million |
+51.67% |
| 2005-06-30 | ZAC2.10 Billion ≈ $1.12 Million |
-- |
About Adcock Ingram Holdings Limited
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products… Read more